SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma. - Wikidata - awgldk - TriplyDB

SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.

SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37113106

about

Proteomic mapping of cytosol-facing outer mitochondrial and ER membranes in living human cells by proximity biotinylation Delta-like ligand 4 in hepatocellular carcinoma intrinsically promotes tumour growth and suppresses hepatitis B virus replication

P2860

Q33603020-8D51607E-48DC-4248-809B-7DD4D13B5297 Q58740348-390EE43B-B2B8-45AD-9C7B-662E624363CB

P2860

SYNJ2BP inhibits tumor growth and metastasis by activating DLL4 pathway in hepatocellular carcinoma.

http://www.wikidata.org/entity/Q37113106

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 July 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

SYNJ2BP inhibits tumor growth ...... y in hepatocellular carcinoma.

@en

SYNJ2BP inhibits tumor growth ...... y in hepatocellular carcinoma.

@nl

type

label

SYNJ2BP inhibits tumor growth ...... y in hepatocellular carcinoma.

@en

SYNJ2BP inhibits tumor growth ...... y in hepatocellular carcinoma.

@nl

prefLabel

SYNJ2BP inhibits tumor growth ...... y in hepatocellular carcinoma.

@en

SYNJ2BP inhibits tumor growth ...... y in hepatocellular carcinoma.

@nl

P1433

Q37113106-85D1DD22-90CA-4652-8B4E-92580406D777

P1476

Q37113106-FAAA3796-9801-4C20-AD5F-5899C3499F4C

P2093

Q37113106-54D2A32A-81F9-466E-9AD6-36BC15E747BC

Q37113106-8059506F-6472-4406-91A2-CA348D911381

Q37113106-B317525A-BF07-46EF-ADB5-AE74366226E1

Q37113106-DCB86121-F4EB-464E-8868-A3AFE57E035E

Q37113106-E0A9F436-15A8-4D06-BFD9-B6E87AA8A981

Q37113106-EEDBCB90-6330-4A4C-9A41-9757D52FCD3A

P2860

Q37113106-02ABFF51-6C4C-45BA-B74F-7A9433E38342

Q37113106-08142AD6-A91E-431D-A676-428926BD9592

Q37113106-08887471-F3D5-42A9-8D35-C8E48075CEE6

Q37113106-0EF0BB2C-55B7-4E7E-BC60-866A178C4F77

Q37113106-11EB882F-30F0-461E-8C90-B7E9B29B2A96

Q37113106-12EBFDA3-41D9-4438-B489-9306F72C81E2

Q37113106-18102511-CDD1-4C61-9EE4-AEE566AAAA36

Q37113106-1A68C4FE-F713-44BC-86F7-F3CF453B6A64

Q37113106-1C3742AB-9F04-465E-A577-770574ADF1C2

Q37113106-25781BCE-1B59-4131-BD96-7CFEE120F76E

P2888

Q37113106-6C75B6BD-55A7-49BF-947B-49371FA5401B

P304

Q37113106-EB9AFC24-9E65-4C3E-A9DE-DF90A53CE043

P31

Q37113106-0953644C-C226-4639-9B11-21284D69AEE5

P356

Q37113106-594A778B-3956-4EFB-B0DC-965C3D19575D

P433

Q37113106-4BAE8BAC-1D54-4767-BB22-FDBA9F1CD300

P478

Q37113106-F7D3182A-3A2D-427D-A614-E577BC09B701

P577

Q37113106-7B84A75F-48CB-47BB-86B3-3AD76D239191

P6179

Q37113106-8CC97F5D-F435-4D04-84ED-AAE0AE4CB495

P698

Q37113106-E5DBA0A6-E5B4-45DA-8D69-FB3355DA821F

P932

Q37113106-DF7E616C-A93D-41FF-9987-A8F3AB265DC5

P356

S13046-016-0385-0

P1433

Journal of Experimental & Clinical Cancer Research

P1476

SYNJ2BP inhibits tumor growth ...... y in hepatocellular carcinoma.

@en

P2093

Jiangjiao Zhou

http://www.w3.org/2001/XMLSchema#string

Jianwei Zhu

http://www.w3.org/2001/XMLSchema#string

Ning Zhou

http://www.w3.org/2001/XMLSchema#string

Xiao Liu

http://www.w3.org/2001/XMLSchema#string

Xiongying Miao

http://www.w3.org/2001/XMLSchema#string

Yong Feng

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Synaptojanin-2 binding protein stabilizes the Notch ligands DLL1 and DLL4 and inhibits sprouting angiogenesis

Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling.

Recruitment of an alternatively spliced form of synaptojanin 2 to mitochondria by the interaction with the PDZ domain of a mitochondrial outer membrane protein.

Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy

Global cancer statistics, 2012

Intertwining of Activin A and TGFβ Signaling: Dual Roles in Cancer Progression and Cancer Cell Invasion

Regulation of endocytosis of activin type II receptors by a novel PDZ protein through Ral/Ral-binding protein 1-dependent pathway

Activin signaling and its role in regulation of cell proliferation, apoptosis, and carcinogenesis

Mesenchymal stem cells within tumour stroma promote breast cancer metastasis

P2888

s13046-016-0385-0

P304

115

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13046-016-0385-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019179694

http://www.w3.org/2001/XMLSchema#string

P698

27440153

http://www.w3.org/2001/XMLSchema#string

P932

4955141

http://www.w3.org/2001/XMLSchema#string